Colorectal Cancer Screening Update: No Specific Test Is Favored

The U.S. Preventive Services Task Force notes that benefits for patients older than 75 are less clear.

Sponsoring Organization: U.S. Preventive Services Task Force (USPSTF)

Target Audience: Primary care providers

Background

The USPSTF has updated its 2008 evidence statement and recommendations for screening asymptomatic adults at average risk for colorectal cancer (NEJM JW Gen Med Nov 15 2008 and Ann Intern Med 2008; 149:627). The Task Force finds strong evidence that middle-aged patients (age range, 50–75) will benefit from screening and has updated its recommendations on testing strategies.

Key Points

Seven tests were assessed for their effectiveness in identifying colorectal cancer. The Task Force found no head-to-head randomized trials in which colorectal cancer–related mortality outcomes were compared for two or more screening modalities; th…

Reviewing Author

Thomas L. Schwenk, MD

Disclosures

Editorial BoardsUpToDate